Effective against Omicron, this treatment reduces the risk of being hospitalized or dying from Covid by around 85%, according to clinical studies.
Article written by
Posted
Reading time : 1 min.
The first deliveries are expected in France within a few days. The High Authority for Health (HAS) gave the green light on Friday January 21 to the use of the antiviral Paxlovid as a curative treatment against Covid 19. Following the opinion of the national medicine agency, the HAS “authorizes early access to the Paxlovid treatment (nirmatrelvir / ritonavir) from the Pfizer laboratory for adults with Covid-19 who do not require oxygen therapy and at high risk of progressing to a severe form of the disease”, specifies-t she in a statement.
It is a treatment primarily intended for populations at risk (very elderly, immunocompromised, suffering from certain rare diseases, etc.). This pill is taken orally as three tablets per day for five days. It is recommended to take it as soon as possible after the positive diagnosis for Covid-19 and at most within five days of the onset of symptoms.
Effective against Omicron, this treatment reduces the risk of being hospitalized or dying from Covid by around 85%, according to clinical studies.